Paper39095877
Prevalence and characteristics of patients with incidental cardiac uptake on bone scintigraphy.
Son J and 2 others. J Cardiovasc Imaging, 2024. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Prevalence and characteristics of patients with incidental cardiac uptake on bone scintigraphy. Papers, record 39095877. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39095877
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Prevalence and characteristics of patients with incidental cardiac uptake on bone scintigraphy.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References16
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27143678 | Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis. | Circulation | 2016 | https://conductscience.org/library/papers/27143678 | PubMed |
| 2 | 104017 | Bone scintigraphy in renal osteodystrophy. | J Nucl Med | 1978 | https://conductscience.org/library/papers/104017 | PubMed |
| 3 | 31480867 | Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis. | Circ Heart Fail | 2019 | https://conductscience.org/library/papers/31480867 | PubMed |
| 4 | 35361352 | Critical Comparison of Documents From Scientific Societies on Cardiac Amyloidosis: JACC State-of-the-Art Review. | J Am Coll Cardiol | 2022 | https://conductscience.org/library/papers/35361352 | PubMed |
| 5 | 31019172 | Prevalence of Positive 99 mTc-DPD Scintigraphy as an Indicator of the Prevalence of Wild-type Transthyretin Amyloidosis in the Elderly. | Int Heart J | 2019 | https://conductscience.org/library/papers/31019172 | PubMed |
| 6 | 31553132 | Transthyretin cardiac amyloidosis: an update on diagnosis and treatment. | ESC Heart Fail | 2019 | https://conductscience.org/library/papers/31553132 | PubMed |
| 7 | 24831216 | Identification of TTR-related subclinical amyloidosis with 99mTc-DPD scintigraphy. | JACC Cardiovasc Imaging | 2014 | https://conductscience.org/library/papers/24831216 | PubMed |
| 8 | 36710122 | Nuclear medicine imaging findings in end-stage renal disease and renal transplant complications. | Clin Radiol | 2023 | https://conductscience.org/library/papers/36710122 | PubMed |
| 9 | 33728572 | The prevalence of TTR cardiac amyloidosis among patients undergoing bone scintigraphy. | J Nucl Cardiol | 2021 | https://conductscience.org/library/papers/33728572 | PubMed |
| 10 | 32476490 | Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association. | Circulation | 2020 | https://conductscience.org/library/papers/32476490 | PubMed |
| 11 | 36799266 | The short and long-term characteristics and outcomes of patients with grade 1 myocardial uptake on cardiac scintigraphy. | ESC Heart Fail | 2023 | https://conductscience.org/library/papers/36799266 | PubMed |
| 12 | 16168294 | Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy. | J Am Coll Cardiol | 2005 | https://conductscience.org/library/papers/16168294 | PubMed |
| 13 | 33826207 | Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. | Eur J Heart Fail | 2021 | https://conductscience.org/library/papers/33826207 | PubMed |
| 14 | 29903517 | Prevalence of wild type ATTR assessed as myocardial uptake in bone scan in the elderly population. | Int J Cardiol | 2018 | https://conductscience.org/library/papers/29903517 | PubMed |
| 15 | 31109193 | Natural History, Quality of Life, and Outcome in Cardiac Transthyretin Amyloidosis. | Circulation | 2019 | https://conductscience.org/library/papers/31109193 | PubMed |
| 16 | 32266575 | Diagnosis of Transthyretin Amyloid Cardiomyopathy. | Cardiol Ther | 2020 | https://conductscience.org/library/papers/32266575 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42325163 | Prevalence of cardiac amyloidosis in screening studies: a systematic review and meta-analysis. | ESC Heart Fail | 2026 | https://conductscience.org/library/papers/42325163 | PubMed |
| 41590238 | Incidental Cardiac Uptake on 99mTc-HMDP Bone Scintigraphy in Oncology Patients: Two Cases of Transthyretin Amyloid Cardiomyopathy with Literature Review. | Diseases | 2026 | https://conductscience.org/library/papers/41590238 | PubMed |
| 39343981 | To see those not to be seen: cardiac uptake on noncardiac imaging. | J Cardiovasc Imaging | 2024 | https://conductscience.org/library/papers/39343981 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39095877
GET https://conductscience.org/api/papers/v1/39095877/authors